Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:1373-1380
Published online before print May 11, 2006, doi: 10.1161/01.RES.0000225987.52765.13
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/11/1373    most recent
01.RES.0000225987.52765.13v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nykänen, A. I.
Right arrow Articles by Lemström, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nykänen, A. I.
Right arrow Articles by Lemström, K. B.
Related Collections
Right arrow Transplantation
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2006;98:1373.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Common Protective and Diverse Smooth Muscle Cell Effects of AAV-Mediated Angiopoietin-1 and -2 Expression in Rat Cardiac Allograft Vasculopathy

Antti I. Nykänen, Katri Pajusola, Rainer Krebs, Mikko A.I. Keränen, Olivier Raisky, Petri K. Koskinen, Kari Alitalo, Karl B. Lemström

From the Cardiopulmonary Research Group, Transplantation Laboratory (A.I.N., R.K., M.A.I.K., P.K.K, K.B.L.), University of Helsinki and Helsinki University Central Hospital; Department of Medicine, Division of Nephrology (P.K.K.), Department of Cardiothoracic Surgery (K.B.L.), Helsinki University Central Hospital; Molecular Cancer Biology Laboratory (K.P., K.A.), Biomedicum Helsinki, University of Helsinki, Finland; and Hôpital Cardiologique Louis Pradel (O.R.), Lyon, France.

Correspondence to Antti Nykänen, MD, Transplantation Laboratory, Haartman Institute, PO Box 21 (Haartmaninkatu 3), FIN-00014 University of Helsinki, Finland. E-mail Antti.Nykanen{at}helsinki.fi

Angiopoietin-1 (Ang1) and Ang2 regulate the maintenance of normal vasculature by direct endothelial and indirect smooth muscle cell (SMC) effects. Dysfunction of vascular wall cells is considered central in cardiac allograft vasculopathy (CAV), where inflammation and arterial injury initiate subsequent intimal SMC proliferation. In this study, we investigated the effect of exogenous Ang1 and Ang2 in chronically rejecting rat cardiac allografts by intracoronary adeno-associated virus (AAV)-mediated gene transfer. Bioluminescent imaging of AAV-transfected syngeneic grafts revealed gradual and stable transgene expression in graft cardiomyocytes. In cardiac allografts, both AAV-Ang1 and AAV-Ang2 decreased inflammation and increased antiapoptotic Bcl-2 mRNA and Bcl-2/Bax ratio at 8 weeks. Only AAV-Ang2 decreased the development of CAV, whereas AAV-Ang1 activated arterial SMC and increased PDGF-A mRNA in the allograft. Collectively, our results show that exogenous Ang1 and Ang2 have similar antiinflammatory and antiapoptotic effects in cardiac allografts. Prolonged AAV-mediated Ang1 transgene expression also induced SMC activation, whereas AAV-Ang2 lacked the SMC activating effects and decreased CAV. Our results thus highlight the common protective and diverse SMC effects of Ang1 and Ang2 in cardiac allograft microenvironment and the importance of timing of angiopoietins to achieve therapeutic effects.


Key Words: endothelium • inflammation • muscle, smooth • angiogenesis • arteriosclerosis • transplantation




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Ahmed, T. Fujisawa, X.-L. Niu, S. Ahmad, B. Al-Ani, K. Chudasama, A. Abbas, R. Potluri, V. Bhandari, C. M. Findley, et al.
Angiopoietin-2 Confers Atheroprotection in apoE-/- Mice by Inhibiting LDL Oxidation via Nitric Oxide
Circ. Res., June 19, 2009; 104(12): 1333 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Anisimov, A. Alitalo, P. Korpisalo, J. Soronen, S. Kaijalainen, V.-M. Leppanen, M. Jeltsch, S. Yla-Herttuala, and K. Alitalo
Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
Circ. Res., June 5, 2009; 104(11): 1302 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Tuuminen, A. I. Nykanen, R. Krebs, J. Soronen, K. Pajusola, M. A.I. Keranen, P. K. Koskinen, K. Alitalo, and K. B. Lemstrom
PDGF-A, -C, and -D but not PDGF-B Increase TGF-{beta}1 and Chronic Rejection in Rat Cardiac Allografts
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Voskas, Y. Babichev, L. S. Ling, J. Alami, Y. Shaked, R. S. Kerbel, B. Ciruna, and D. J. Dumont
An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice
J. Leukoc. Biol., July 1, 2008; 84(1): 59 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hu, A. Dandapat, L. Sun, J. A. Khan, Y. Liu, P. L. Hermonat, and J. L. Mehta
Regulation of TGF{beta}1-mediated Collagen Formation by LOX-1: Studies Based on Forced Overexpression of TGF{beta}1 in Wild-Type and Lox-1
J. Biol. Chem., April 18, 2008; 283(16): 10226 - 10231.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-P. Hu, A. Dandapat, Y. Liu, P. L. Hermonat, and J. L. Mehta
Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1833 - H1838.
[Abstract] [Full Text] [PDF]